Profilo
Hans Vassgård Eid is currently Chairman at Snøtind AS.
Former positions include Investment Director at Foinco Invest AS from 2002 to 2007, Director at Pharmaq AS from 2012 to 2015, Senior Vice President-Business Development at Storebrand ASA from 1998 to 2001, Chief Executive & Financial Officer at Ultimovacs ASA, and Chief Financial Officer at Zelluna ASA. Education includes an MBA from the Norwegian School of Economics & Business Administration.
Posizioni attive di Hans Vassgård Eid
| Società | Posizione | Inizio |
|---|---|---|
Snøtind AS | Presidente | - |
Precedenti posizioni note di Hans Vassgård Eid
| Società | Posizione | Fine |
|---|---|---|
Pharmaq AS
Pharmaq AS Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company | Direttore/Membro del Consiglio | 01/01/2015 |
Foinco Invest AS
Foinco Invest AS Investment ManagersFinance Acts as an alternative investment manager | Direttore degli Investimenti | 01/01/2007 |
| STOREBRAND ASA | Corporate Officer/Principal | 01/01/2001 |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Amministratore Delegato | - |
Formazione di Hans Vassgård Eid
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Storebrand ASA
Storebrand ASA Savings BanksFinance Provides savings, insurance and guaranteed pension services | Finance |
Foinco Invest AS
Foinco Invest AS Investment ManagersFinance Acts as an alternative investment manager | Finance |
Pharmaq AS
Pharmaq AS Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company | Health Technology |
Norwegian School of Economics & Business Administration
Norwegian School of Economics & Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Snøtind AS |
















